Cargando…
Partial MHC/Neuroantigen Peptide Constructs: A Potential Neuroimmune-Based Treatment for Methamphetamine Addiction
Relapse rates following current methamphetamine abuse treatments are very high (∼40–60%), and the neuropsychiatric impairments (e.g., cognitive deficits, mood disorders) that arise and persist during remission from methamphetamine addiction likely contribute to these high relapse rates. Pharmacother...
Autores principales: | Loftis, Jennifer M., Wilhelm, Clare J., Vandenbark, Arthur A., Huckans, Marilyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584080/ https://www.ncbi.nlm.nih.gov/pubmed/23460798 http://dx.doi.org/10.1371/journal.pone.0056306 |
Ejemplares similares
-
Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence
por: Loftis, Jennifer M., et al.
Publicado: (2019) -
Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study
por: Huckans, Marilyn, et al.
Publicado: (2015) -
Spleen participation in partial MHC class II construct neuroprotection in stroke
por: Brown, John, et al.
Publicado: (2020) -
Sex-dependent treatment of chronic EAE with partial MHC class II constructs
por: Benedek, Gil, et al.
Publicado: (2017) -
Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine
por: Loftis, Jennifer M., et al.
Publicado: (2023)